NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.47
+0.19 (1.33%)
Aug 18, 2026, 4:00 PM EDT - Market closed

NeuroPace Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
106.9999.9979.9165.4245.5245.18
Revenue Growth
33.16%25.13%22.14%43.72%0.75%9.83%
Gross Profit
82.7977.2259.0948.1232.4933.44
Operating Income
-12.14-16.34-21.67-27.17-40.79-23.74
Net Income
-19.11-21.47-27.14-32.96-47.08-36.08
Earnings Per Share
-0.57-0.66-0.93-1.27-1.91-2.17
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
United States
105.3999.0979.71
Foreign
1.60.90.2
Total
106.9999.9979.91

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
51.761.0652.7666.4577.41115.58
Total Debt
69.9370.8473.3472.469.7749.85
Net Cash (Debt)
-18.23-9.78-20.58-5.947.6465.74
Net Cash Growth
-----88.38%-
Net Cash Per Share
-0.54-0.30-0.71-0.230.313.96

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.24-11.01-17.95-19.7-36.87-24.58
Capital Expenditures
-0.37-0.33-0.31-0.17-0.6-0.38
Free Cash Flow
-11.61-11.34-18.26-19.87-37.47-24.96
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
77.38%77.23%73.94%73.56%71.38%74.00%
Operating Margin
-11.34%-16.34%-27.12%-41.54%-89.62%-52.53%
Pretax Margin
-15.12%-21.47%-33.97%-50.38%-103.43%-79.85%
Profit Margin
-17.87%-21.47%-33.97%-50.38%-103.43%-79.85%
FCF Margin
-10.85%-11.34%-22.85%-30.38%-82.32%-55.24%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.645.144.184.140.825.42